Ghrelin ameliorates cognitive dysfunction and neurodegeneration in intrahippocampal amyloid-β1-42 oligomer-injected mice

Journal of Alzheimer's Disease

Volumn 23, Issue 1, 2011, Pages 147-159

  Moon, Minho ^a   Choi, Jin Gyu ^c   Nam, Dong Woo ^a,b   Hong, Hyun Seok ^a   Choi, Young Ju ^a   Oh, Myung Sook ^c   Mook Jung, Inhee ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Kyung Hee University   (South Korea)

Author keywords

Alzheimer's disease; amyloid oligomer; cognitive impairment; ghrelin; neurodegeneration; neuroinflammation

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; GHRELIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LOSS; CHOLINERGIC NERVE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; GLIOSIS; HIPPOCAMPUS; MALE; MEMORY DISORDER; MOUSE; NERVE CELL; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SYNAPSE;

EID: 78651359641     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-101263     Document Type: Article

References (66)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656-660.
2. Guan XM, Yu H, Palyha OC, McKee KK, Feighner SD, Sirinathsinghji DJ, Smith RG, Van der Ploeg LH, Howard AD (1997) Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res Mol Brain Res 48, 23-29. (Pubitemid 27298124)
3. Zigman JM, Jones JE, Lee CE, Saper CB, Elmquist JK (2006) Expression of ghrelin receptor mRNA inthe rat and the mouse brain. J Comp Neurol 494, 528-548.
4. Moon M, Kim S, Hwang L, Park S (2009) Ghrelin regulates hippocampal neurogenesis in adult mice. Endocr J 56, 525-531.
5. Diano S, Farr SA, Benoit SC, McNay EC, da Silva I, Horvath B, Gaskin FS, Nonaka N, Jaeger LB, Banks WA, Morley JE, Pinto S, Sherwin RS, Xu L, Yamada KA, Sleeman MW, Tschop MH, Horvath TL (2006) Ghrelin controls hippocam-pal spine synapse density and memory performance. Nat Neurosci 9, 381-388.
6. van der Lely AJ, Tschop M, Heiman ML, Ghigo E (2004) Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 25, 426-457.
7. Leite-Moreira AF, Soares JB (2007) Physiological, pathological and potential therapeutic roles of ghrelin. Drug Discov Today 12, 276-288.
8. Carlini VP, Varas MM, Cragnolini AB, Schioth HB, Scimonelli TN, deBarioglioSR(2004) Differential roleofthe hippocampus, amygdala, and dorsal raphe nucleus in regulating feeding, memory, and anxiety-like behavioral responses to ghrelin. Biochem Biophys Res Commun 313, 635-641.
9. McNay EC (2007) Insulin and ghrelin: peripheral hormones modulating memory and hippocampal function. Curr Opin Pharmacol 7, 628-632.
10. Carlini VP, Ghersi M, Schioth HB, de Barioglio SR (2010) Ghrelin and memory: differential effects on acquisition and retrieval. Peptides 31, 1190-1193.
11. Johansson I, Destefanis S, Aberg ND, Aberg MA, Blomgren K, Zhu C, Ghe C, Granata R, Ghigo E, Muccioli G, Eriksson PS, Isgaard J (2008) Proliferative and protective effects of growth hormone secretagogues on adult rat hippocampal progenitor cells. Endocrinology 149, 2191-2199.
12. BarlindA,KarlssonN,Berg ND, Bjork-ErikssonT,Blomgren K, Isgaard J (2010) Thegrowth hormone secretagogue hexare-lin increases cell proliferation in neurogenic regions of the mouse hippocampus. Growth Horm IGF Res 20, 49-54.
13. Chung H, Kim E, Lee DH, Seo S, Ju S, Lee D, Kim H, Park S (2007) Ghrelin inhibits apoptosis in hypothalamic neuronal cells during oxygen-glucose deprivation. Endocrinology 148, 148-159.
14. Yang M, Hu S, Wu B, Miao Y, Pan H, Zhu S (2007) Ghre-lin inhibits apoptosis signal-regulating kinase 1 activity via upregulating heat-shock protein 70. Biochem Biophys Res Commun 359, 373-378.
15. Moon M, Kim HG, Hwang L, Seo JH, Kim S, Hwang S, Lee D, Chung H, Oh MS, Lee KT, Park S (2009) Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation. Neurotox Res 15, 332-347.
16. Andrews ZB, Erion D, Beiler R, Liu ZW, Abizaid A, Zigman J, Elsworth JD, Savitt JM, DiMarchi R, Tschoep M, Roth RH, Gao XB, Horvath TL (2009) Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism. J Neurosci 29, 14057-14065.
17. Delgado-Rubin de Celix A, Chowen JA, Argente J, Frago LM (2006) Growth hormone releasing peptide-6 acts as a survival factor in glutamate-induced excitotoxicity. J Neurochem 99, 839-849.
18. LiuY, Wang PS, Xie D, Liu K, ChenL(2006) Ghrelin reduces injury of hippocampal neurons in a rat model of cerebral ischemia/reperfusion. Chin J Physiol 49, 244-250.
19. Xu J, Wang S, Lin Y, Cao L, Wang R, Chi Z (2009) Ghrelin protects against cell death of hippocampal neurons in pilocarpine-induced seizures in rats. Neurosci Lett 453, 58-61.
20. Liu Y, Chen L, Xu X, Vicaut E, Sercombe R (2009) Both ischemic preconditioning and ghrelin administration protect hippocampus from ischemia/reperfusion and upregulate uncoupling protein-2. BMC Physiol 9, 17.
21. Lee J, Lim E, Kim Y, Li E, Park S (2010) Ghrelin attenuates kainic acid-induced neuronal cell death in the mouse hippocampus. J Endocrinol 205, 263-270.
22. Miao Y, Xia Q, Hou Z, Zheng Y, Pan H, Zhu S (2007) Ghrelin protects cortical neuron against focal ischemia/reperfusion in rats. Biochem Biophys Res Commun 359, 795-800.
23. Hwang S, Moon M, Kim S, Hwang L, Ahn KJ, Park S (2009) Neuroprotective effect of ghrelin is associated with decreased expression of prostate apoptosis response-4. Endocr J 56, 609-617.
24. Jiang H, Li LJ, Wang J, Xie JX (2008) Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra. Exp Neurol 212, 532-537.
25. Dong J, Song N, Xie J, Jiang H (2009) Ghrelin antagonized 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells. J Mol Neurosci 37, 182-189.
26. Theil MM, Miyake S, Mizuno M, Tomi C, Croxford JL, Hosoda H, Theil J, von Horsten S, Yokote H, Chiba A, Lin Y, Oki S, Akamizu T, Kangawa K, Yamamura T (2009) Suppression of experimental autoimmune encephalomyelitis by ghrelin. J Immunol 183, 2859-2866.
27. Obay BD, Tasdemir E, TumerC, Bilgin HM, Sermet A (2007) Antiepileptic effectsof ghrelinonpentylenetetrazole-induced seizures in rats. Peptides 28, 1214-1219.
28. Lee JY, Chung H, Yoo YS, Oh YJ, Oh TH, Park S, Yune TY (2010) Inhibition of apoptotic cell death by ghrelin improves functional recovery after spinal cord injury. Endocrinology 151, 3815-3826.
29. Selkoe DJ (1994) Alzheimer's disease: a central role for amyloid. J Neuropathol Exp Neurol 53, 438-447.
30. Sakono M, Zako T (2010) Amyloid oligomers: formation and toxicity of Abeta oligomers. FEBS J 277, 1348-1358.
31. Hong HS, Rana S, Barrigan L, Shi A, Zhang Y, Zhou F, Jin LW, Hua DH (2009) Inhibition of Alzheimer's amyloid tox-icity with a tricyclic pyrone molecule in vitro and in vivo. J Neurochem 108, 1097-1108.
32. Maezawa I, Hong HS, Wu HC, Battina SK, Rana S, Iwamoto T, Radke GA, Pettersson E, Martin GM, Hua DH, Jin LW (2006)A novel tricyclic pyrone compound ameliorates cell death associated with intracellular amyloid-beta oligomeric complexes. J Neurochem 98, 57-67.
33. Obay BD, Tasdemir E, Tumer C, Bilgin HM, Atmaca M (2008) Dose dependent effects of ghrelin on pentylen-etetrazole-induced oxidative stress in a rat seizure model. Peptides 29, 448-455.
34. Cancino GI, Toledo EM, Leal NR, Hernandez DE, Yevenes LF, Inestrosa NC, Alvarez AR (2008) STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer's beta-amyloid deposits. Brain 131, 2425-2442.
35. Huang HJ, Liang KC, Chen CP, Chen CM, Hsieh-Li HM (2007)Intrahippocampal administration of A beta(1-40) impairs spatial learning and memory in hyperglycemic mice. Neurobiol Learn Mem 87, 483-494.
36. Paxinos G, Franklin KBJ (2001) The Mouse Brain in Stereo-taxic Coordinates, Academic Press, San Diego.
37. Kim DH, Jeon SJ, Son KH, Jung JW, Lee S, Yoon BH, Lee JJ, Cho YW, Cheong JH, Ko KH, Ryu JH (2007) The ameliorating effect of oroxylin A on scopolamine-induced memory impairment in mice. Neurobiol Learn Mem 87, 536-546.
38. Bang OY, Hong HS, Kim DH, KimH,Boo JH, HuhK,Mook-Jung I (2004) Neuroprotective effect of genistein against beta amyloid-induced neurotoxicity. Neurobiol Dis 16, 21-28.
39. Bales KR, Tzavara ET, Wu S, Wade MR, Bymaster FP, Paul SM, Nomikos GG (2006) Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A beta antibody. J Clin Invest 116, 825-832.
40. Dinamarca MC, Cerpa W, Garrido J, Hancke JL, Inestrosa NC (2006) Hyperforin prevents beta-amyloid neurotoxi-city and spatial memory impairments by disaggregation of Alzheimer's amyloid-beta-deposits. Mol Psychiatry 11, 1032-1048.
41. Banks WA, Tschop M, Robinson SM, Heiman ML (2002) Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther 302, 822-827.
42. Walsh DM, Selkoe DJ (2004) Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44, 181-193.
43. McGeer PL, Itagaki S, Tago H, McGeer EG (1987) Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett 79, 195-200.
44. Block ML, ZeccaL,HongJS(2007) Microglia-mediated neu-rotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8, 57-69.
45. Ersahin M, Toklu HZ, Erzik C, Cetinel S, Bangir D, Ogunc AV, Tetik S, Ozdemir ZN, Sener G, Yegen BC (2010) The anti-inflammatory and neuroprotective effects of ghrelin in subarachnoid hemorrhage-induced oxidative brain damage in rats. J Neurotrauma 27, 1143-1155.
46. Pickering M, Cumiskey D, O'Connor JJ (2005) Actions of TNF-alpha onglutamatergic synaptic transmission inthe central nervous system. Exp Physiol 90, 663-670.
47. Holmes C, Cunningham C, Zotova E, Woolford J, Dean C, Kerr S, Culliford D, Perry VH (2009) Systemic inflammation and disease progression in Alzheimer disease. Neurology 73, 768-774.
48. Loo DT, Copani A, Pike CJ, Whittemore ER, Walencewicz AJ, Cotman CW(1993) Apoptosisisinducedbybeta-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci USA 90, 7951-7955.
49. Behl C, Davis JB, Lesley R, Schubert D (1994) Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77, 817-827.
50. Schubert D, Behl C, Lesley R, Brack A, Dargusch R, Sagara Y, Kimura H (1995) Amyloid peptides are toxic via a common oxidative mechanism. Proc Natl Acad Sci USA 92, 1989-1993.
51. Eckert A, Keil U, Marques CA, Bonert A, Frey C, Schussel K, Muller WE (2003) Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease. Biochem Pharmacol 66, 1627-1634. (Pubitemid 38373355)
52. Harkany T, Abraham I, Timmerman W, Laskay G, Toth B, Sasvari M, Konya C, Sebens JB, Korf J, Nyakas C, Zarandi M, Soos K, Penke B, Luiten PG (2000) Beta-amyloid neu-rotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis. Eur J Neurosci 12, 2735-2745.
53. Chung H, Seo S, Moon M, Park S (2008) Phosphatidyl-inositol-3-kinase/Akt/ glycogen synthase kinase-3 beta and ERK1/2 pathways mediate protective effects of acylated and unacylated ghrelin against oxygen-glucose deprivation-induced apoptosis in primary rat cortical neuronal cells. J Endocrinol 198, 511-521.
54. Delgado-Rubin A, Chowen JA, Argente J, Frago LM (2009) Growth hormone-releasing peptide 6 protection of hypotha-lamic neurons from glutamate excitotoxicity is caspase independent and not mediated by insulin-like growth factor I. Eur J Neurosci 29, 2115-2124.
55. Masliah E, Mallory M, Alford M, DeTeresa R, Hansen LA, McKeel DW Jr, Morris JC (2001) Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology 56, 127-129.
56. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30, 572-580.
57. Buttini M, Yu GQ, Shockley K, Huang Y, Jones B, Masliah E, MalloryM, YeoT, Longo FM, MuckeL (2002) Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpressionofamyloid beta peptides but noton plaque formation. J Neurosci 22, 10539-10548.
58. Perry E, Walker M, Grace J, Perry R (1999) Acetylcholine in mind: a neurotransmitter correlate of consciousness? Trends Neurosci 22, 273-280.
59. Tschop M, Smiley DL, Heiman ML (2000) Ghrelin induces adiposity in rodents. Nature 407, 908-913.
60. Guenette SY (2003) Astrocytes: a cellular player in Abeta clearance and degradation. Trends Mol Med 9, 279-280.
61. Mandrekar S, Jiang Q, Lee CY, Koenigsknecht-Talboo J, Holtzman DM, Landreth GE (2009) Microglia mediate the clearance of soluble Abeta through fluid phase macropinocy-tosis. J Neurosci 29, 4252-4262.
62. Gillette-Guyonnet S, Nourhashemi F, Andrieu S, de Glisezinski I, Ousset PJ, Riviere D, Albarede JL, Vellas B (2000) Weight loss in Alzheimer disease. Am J Clin Nutr 71, 637S-642S.
63. Purandare N, Burns A, Craig S, Faragher B, Scott K (2001) Depressive symptoms in patients with Alzheimer's disease. Int J Geriatr Psychiatry 16, 960-964.
64. Lopez-Toledano MA, Ali Faghihi M, Patel NS, Wahlestedt C (2010) Adult neurogenesis:apotential tool for early diagnosis in Alzheimer's disease? J Alzheimers Dis 20, 395-408.
65. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S (2001) A role for ghrelin in the central regulation of feeding. Nature 409, 194-198.
66. Lutter M, Sakata I, Osborne-Lawrence S, Rovinsky SA, Anderson JG, Jung S, Birnbaum S, Yanagisawa M, Elmquist JK, Nestler EJ, Zigman JM (2008) The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nat Neurosci 11, 752-753.